The sites in Franklin and San Jose are the first of Thermo Fisher’s liquid chromatography and mass spectrometry sites to achieve ISO 13485 certification. 

Thermo Scientific TLX multiplexed HPLC (high performance liquid chromatography) platforms and a number of Thermo Scientific mass spectrometry systems will be designed and manufactured under this standard, paving the way for CE-IVD device registration in Europe and Class-1 medical device listing in the United States, the company said. 

“This is a critical step in our ongoing initiative to develop LC-MS-based devices for the clinical market,” said Dan Shine, president of Thermo Fisher’s chromatography and mass spectrometry business. “The medical community is expressing great interest in utilizing LC-MS technology, and we’re aggressively developing tools to address this growing demand.”